Targeting Cancer with Peptide RNAi Nanoplexes.

Area of Science:

• Biotechnology and Biomedical Engineering
• Molecular Biology and Genetics
• Nanotechnology in Medicine

Background:

• Growing genomic data necessitates advanced nucleic acid delivery systems for therapeutics like siRNA and gene therapy.
• Nucleic acids (siRNA, plasmids) are highly charged, posing challenges for effective delivery to target cells.
• Peptide and polymeric carriers offer potential solutions for overcoming these delivery hurdles.

Purpose of the Study:

• To describe the preparation and characterization of nanoplexes formed by peptide carriers and nucleic acids.
• To evaluate the potential of these nanoplexes for delivering shRNA or siRNA targeting oncogenes for cancer treatment.
• To provide protocols for in vitro and in vivo transfection using these nanoplexes.

Main Methods:

• Formation of nanoplexes through ionic and nonionic interactions between histidine-lysine (HK) peptides and nucleic acids (shRNA/siRNA).
• Characterization of nanoplexes using dynamic light scattering, zeta potential, and gel retardation assays.
• Development of protocols for in vitro and in vivo transfection experiments.

Main Results:

• HK peptides successfully formed stable nanoplexes with siRNA and shRNA.
• Characterization methods confirmed the formation and properties of these nanoplexes.
• Protocols for transfection demonstrated the utility of nanoplexes for gene delivery.

Conclusions:

• Peptide-based carriers, exemplified by the HK peptide, are effective in forming nanoplexes for nucleic acid delivery.
• These nanoplexes loaded with shRNA or siRNA targeting oncogenes represent a promising strategy for cancer therapy.
• The described methods facilitate the preparation, characterization, and application of these novel therapeutic delivery systems.